Table 2a.
Baseline global network measures between distinct clinical subtypes of Parkinson's disease, defined at baseline and after 4.5 years of follow-up (n = 144).
(Values in each cell represent the average z-score of each measure in each subtype).
| Parkinson's disease clinical subtypes at baseline | ||||
|---|---|---|---|---|
| Global Network Metrics | Mild Motor-predominant | Intermediate | Diffuse malignant | Corrected p-value fdr |
| Global efficiency | 0.05527 | 0.12158 | −0.7406 | 0.033 |
| Characteristic path length | −0.0305 | −0.1454 | 0.67711 | 0.033 |
| Mean clustering coefficient | 0.04291 | 0.01003 | −0.2857 | 0.526 |
| Parkinson's Disease Clinical Subtypes at Follow-up | ||||
| Global Network Metrics | Mild Motor-predominant | Intermediate | Diffuse malignant | Corrected p-value fdr |
| Global efficiency | 0.17531 | 6.1E-06 | −0.9094 | <0.001 |
| Characteristic path length | −0.1715 | −0.0345 | 0.98657 | <0.001 |
| Mean clustering coefficient | 0.05012 | 0.01606 | −0.3052 | 0.428 |